论文部分内容阅读
目的:探讨孟鲁司特钠辅助治疗支气管哮喘的实际效果。方法:选取2012年06月~2014年06月支气管哮喘患者50例,按硬币法分组,25例对照组患者应用布地奈德雾化吸入治疗,25例实验组在对照组基础上应用孟鲁司特钠治疗,比较临床疗效。结果:实验组患者支气管哮喘治疗有效率优于对照组,治疗后实验组ACT评分为(23.61±5.32)分,哮喘控制有效率为84.0%,与对照组的(18.62±3.21)分、64.0%相比,有统计学意义(P<0.05)。结论:孟鲁司特钠辅助治疗支气管哮喘,效果佳,值得进一步应用。
Objective: To investigate the practical effect of montelukast on adjuvant bronchial asthma. Methods: Fifty patients with bronchial asthma were selected from June 2012 to June 2014 and were divided into two groups according to the coin method. 25 patients in the control group were treated with budesonide inhalation. 25 patients in the experimental group were treated with montelukast Special sodium treatment, more clinical efficacy. Results: The effective rate of bronchial asthma in experimental group was better than that in control group. The ACT score of experimental group was (23.61 ± 5.32), the effective rate of asthma control was 84.0%, which was significantly higher than that of control group (18.62 ± 3.21), 64.0% Compared with the statistical significance (P <0.05). Conclusion: Montelukast adjuvant treatment of bronchial asthma, good effect, it is worth further application.